PROMETHAZINE W/ CODEINE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 6 USDMF, 20 CEP/COS, 2 JDMF, 1 EU WC, 8 KDMF, 10 NDC API, 15 Listed Suppliers

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

568 FDF Dossiers, 187 FDA Orange Book, 155 Europe, 48 Canada, 135 South Africa, 43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 300MG;60MG, SYRUP;ORAL - 10MG/5ML;6.25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 7 SPI Pharma, 2 Pharm-RX Chemical, 7 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 7 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 14 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 31 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 1 Clariant, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 15 Kerry, 3 Keval Exports, 3 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 34 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 37 Direct Compression, 37 Thickeners and Stabilizers, 37 Disintegrants & Superdisintegrants, 33 Granulation, 28 Solubilizers, 26 Parenteral, 23 Topical, 21 Taste Masking, 21 Lubricants & Glidants, 19 Film Formers & Plasticizers, 15 Controlled & Modified Release, 14 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 12 Coating Systems & Additives, 9 API Stability Enhancers, 9 Emulsifying Agents, 8 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Rheology Modifiers, 1 Soft Gelatin

DIGITAL CONTENT

20 News #PharmaBuzz

20 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 Regulatory FDF Prices

19 Regulatory FDF Prices

MARKET PLACE

30 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 Others

Xls

Filters

PROMETHAZINE W/ CODEINE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for PROMETHAZINE W/ CODEINE? Find Coloring Agents used in PROMETHAZINE W/ CODEINE to address drug delivery challenges on PharmaCompass.

PROMETHAZINE W/ CODEINE

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

6 USDMF

20 CEP/COS

2 JDMF

1 EU WC

8 KDMF

10 NDC API

15 Listed Suppliers

DEVELOPMENTS

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

568 FDF Dossiers

187 FDA Orange Book

155 Europe

48 Canada

135 South Africa

43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET;ORAL - 300MG;15MG

TABLET;ORAL - 300MG;30MG

TABLET;ORAL - 300MG;60MG

TABLET;ORAL - 300MG;60MG

SYRUP;ORAL - 10MG/5ML;6.25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

7 SPI Pharma

2 Pharm-RX Chemical

7 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

7 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

14 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

31 BASF

1 Bioplus Life Sciences

3 CD Formulation

1 Clariant

7 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

4 Ingredion Pharma Solutions

15 Kerry

3 Keval Exports

3 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qualicaps

34 Roquette

7 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

CAPSULE;ORAL - 325MG;50MG;40MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SYRUP;ORAL - 10MG/5ML;6.25MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons